Joshua Brumm
Overview
Joshua Brumm received an average of $5M in total compensation, including $438K in salary, at Dyne Therapeutics from 2019 to 2022. Joshua Brumm also received an average of $2M at Kaleido Biosciences between 2018 and 2019.
- 2022
- 2021
- 2020
- 2019
- 2018
Dyne TherapeuticsPresident and Chief Executive Officer
Dyne TherapeuticsPresident and Chief Executive Officer
Dyne TherapeuticsPresident and Chief Executive Officer
Dyne TherapeuticsPresident and Chief Executive Officer
Kaleido BiosciencesChief Operating Officer and Chief Financial Officer former principal financial officer
Kaleido BiosciencesChief Operating Officer and Chief Financial Officer former principal financial officer
Source: SEC filings on April 7, 2023, April 22, 2022, April 14, 2021, and May 8, 2020.
Related executives
We found ten more executives who work or worked at Dyne Therapeutics and Kaleido Biosciences.
Josh Brumm
Dyne Therapeutics
Chief Executive Officer
Jonathan McNeill
Dyne Therapeutics
Chief Business Officer
Susanna High
Dyne Therapeutics
Chief Operating Officer
Oxana Beskrovnaya
Dyne Therapeutics
Chief Scientific Officer
Romesh Subramanian
Dyne Therapeutics
Chief Scientific Officer
Daniel Menichella
Kaleido Biosciences
Chief Executive Officer
Katharine Knobil
Kaleido Biosciences
Chief Marketing Officer
William Duke
Kaleido Biosciences
Chief Financial Officer
News
Dyne Therapeutics CEO Joshua Brumm's 2022 pay rises 6% to $4.3M
April 7, 2023
Dyne Therapeutics CEO Joshua Brumm's 2021 pay falls 66% to $4.1M
April 22, 2022
Dyne Therapeutics CEO Joshua Brumm's 2020 pay jumps 981% to $12M
April 14, 2021
Kaleido Biosciences CEO Alison Lawton's 2019 pay falls 57% to $2.9M
May 8, 2020